Overview
Xuejun Deng practices practicing medicine in Wuhan, China.
Their clinical expertise encompasses Benign Familial Neonatal Seizures, Epilepsy, Seizures, and Absence Seizure.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xuejun Deng
Is Xuejun Deng a top-rated expert for Benign Familial Neonatal Seizures?
MediFind is an objective health platform that identifies experts based on real-world data. Xuejun Deng is classified as an Experienced expert for Benign Familial Neonatal Seizures, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xuejun Deng participate in research or clinical trials?
Yes. Xuejun Deng has published 10 articles and abstracts on conditions like Benign Familial Neonatal Seizures. You can view a list of Xuejun Deng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Absence SeizureDeng isExperienced. Learn about Absence Seizure.
- Benign Familial Neonatal Seizures
- EpilepsyDeng isExperienced. Learn about Epilepsy.
- Generalized Tonic-Clonic Seizure
- SeizuresDeng isExperienced. Learn about Seizures.